Indications of BAL, lung biopsy, or both in mechanically ventilated patients with unexplained infiltrations Papazian L., Gainnier M. Eur Respir J 2003; 21: 383-384 | |
Mechanical insufflation/exsufflation: has it come of age? A commentary Bach J.R. Eur Respir J 2003; 21: 385-386 | |
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α Laan M., Prause O., Miyamoto M., Sjostrand M., Hytonen A.M., Kaneko T., Lotvall J., Linden A. Eur Respir J 2003; 21: 387-393 | |
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Blesa S., Cortijo J., Mata M., Serrano A., Closa D., Santangelo F., Estrela J.M., Suchankova J., Morcillo E.J. Eur Respir J 2003; 21: 394-400 | |
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Tsang K.W., Ng P., Ho P.L., Chan S., Tipoe G., Leung R., Sun J., Ho J.C., Ip M.S., Lam W.K. Eur Respir J 2003; 21: 401-406 | |
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Ziegenhagen M.W., Rothe M.E., Schlaak M., Muller-Quernheim J. Eur Respir J 2003; 21: 407-413 | |
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach Sabounchi-Schutt F., Astrom J., Hellman U., Eklund A., Grunewald J. Eur Respir J 2003; 21: 414-420 | |
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Fehrenbach H., Zissel G., Goldmann T., Tschernig T., Vollmer E., Pabst R., Muller-Quernheim J. Eur Respir J 2003; 21: 421-428 | |
Exhaled nitric oxide after lung transplantation: impact of the native lung Verleden G.M., Dupont L.J., Delcroix M., Van Raemdonck D., Vanhaecke J., Lerut T., Demedts M. Eur Respir J 2003; 21: 429-432 | |
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Kharitonov S.A., Gonio F., Kelly C., Meah S., Barnes P.J. Eur Respir J 2003; 21: 433-438 | |
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease Paredi P., Caramori G., Cramer D., Ward S., Ciaccia A., Papi A., Kharitonov S.A., Barnes P.J. Eur Respir J 2003; 21: 439-443 | |
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema Ferrarotti I., Zorzetto M., Beccaria M., Gile L.S., Porta R., Ambrosino N., Pignatti P.F., Cerveri I., Pozzi E., Luisetti M. Eur Respir J 2003; 21: 444-449 | |
Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Boschetto P., Miniati M., Miotto D., Braccioni F., De Rosa E., Bononi I., Papi A., Saetta M., Fabbri L.M., Mapp C.E. Eur Respir J 2003; 21: 450-454 | |
Agreement between written and video questions for comparing asthma symptoms in ISAAC Crane J., Mallol J., Beasley R., Stewart A., Asher M.I. Eur Respir J 2003; 21: 455-461 | |
Long-term mortality among adults with or without asthma in the PAARC study Vandentorren S., Baldi I., Annesi Maesano I., Charpin D., Neukirch F., Filleul L., Cantagrel A., Tessier J.F. Eur Respir J 2003; 21: 462-467 | |
Long-term changes in adult asthma prevalence Brogger J., Bakke P., Eide G.E., Johansen B., Andersen A., Gulsvik A. Eur Respir J 2003; 21: 468-472 | |
Bronchial asthma causing symptoms suggestive of angina pectoris Kiss D., Veegh W., Schragel D., Bachl C., Stollberger C., Sertl K. Eur Respir J 2003; 21: 473-477 | |
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment The Research Committee of the British Thoracic Society Eur Respir J 2003; 21: 478-482 | |
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis Schon T., Elias D., Moges F., Melese E., Tessema T., Stendahl O., Britton S., Sundqvist T. Eur Respir J 2003; 21: 483-488 | |
Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients Bulpa P.A., Dive A.M., Mertens L., Delos M.A., Jamart J., Evrard P.A., Gonzalez M.R., lnstalle E.J. Eur Respir J 2003; 21: 489-494 | |
Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury Tsangaris I., Lekka M.E., Kitsiouli E., Constantopoulos S., Nakos G. Eur Respir J 2003; 21: 495-501 | |
Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness Chatwin M., Ross E., Hart N., Nickol A.H., Polkey M.I., Simonds A.K. Eur Respir J 2003; 21: 502-508 | |
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Marrone O., Salvaggio A., Bonsignore M.R., Insalaco G., Bonsignore G. Eur Respir J 2003; 21: 509-514 | |
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Mar J., Rueda J.R., Duran-Cantolla J., Schechter C., Chilcott J. Eur Respir J 2003; 21: 515-522 | |
Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response Browne H.A.K., Adams L., Simonds A.K., Morrell M.J. Eur Respir J 2003; 21: 523-529 | |
The pattern and timing of breathing during incremental exercise: a normative study Neder J.A., Dal Corso S., Malaguti C., Reis S., De Fuccio M.B., Schmidt H., Fuld J.P., Nery L.E. Eur Respir J 2003; 21: 530-538 | |
Immunological mechanisms in pleural disease Antony V.B. Eur Respir J 2003; 21: 539-544 | |
Pulmonary actinomycosis Mabeza G.F., Macfarlane J. Eur Respir J 2003; 21: 545-551 | |
Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer Radzikowska E., Szczepulska E., Chabowski M., Bestry I. Eur Respir J 2003; 21: 552-555 | |
The European Community Respiratory Health Survey II Knox J., Jarvis D., on behalf of the ... Eur Respir J 2003; 21: 556-560 | |
From the Authors Walters E.H. Eur Respir J 2003; 21: 556 | |
Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed? Connolly C.K. Eur Respir J 2003; 21: 556-557 | |
From the Authors Rennard S.I., Decramer M., Calverley P.M.A., Pride N.B., Soriano J.B., Vermeire P.A., Vestbo J. Eur Respir J 2003; 21: 557 | |
Noninvasive ventilation in stable chronic obstructive pulmonary disease Kohnlein T., Welte T. Eur Respir J 2003; 21: 558 | |
From the Authors Clini E., Ambrosino N. Eur Respir J 2003; 21: 558-559 | |
Survival in COPD patients after regular use of fluticasone propionate and salmeterol Marchand E. Eur Respir J 2003; 21: 559-560 | |
From the Authors Soriano J.B., Vestbo J., Pride N.B. Eur Respir J 2003; 21: 560 | |
Public health and medicolegal implications of sleep apnoea. W.T. McNicholas and J. Krieger on behalf of the Task Force members. Eur Respir J 2003; 21: 561 | |